
Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after markets closed on Tuesday.
The US drug maker reported adjusted earnings of $6.02 per share, up 21% year over year, beating the consensus of $5.24.